Literature DB >> 22297732

Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease.

S A Jamal1, A M Cheung, S L West, C E Lok.   

Abstract

UNLABELLED: Fractures are common in chronic kidney disease (CKD). We determined if bone mineral density testing by dual energy X-ray absorptiometry (DXA) and high resolution peripheral quantitative computed tomography (HR pQCT) could discriminate fracture status in CKD patients. Both tests were able to discriminate fracture status. Further, the addition of HR pQCT measurements to DXA measurements did not improve fracture discrimination.
INTRODUCTION: The optimal method to identify individuals with CKD at high fracture risk is unknown.
METHODS: We determined if bone mineral density (BMD) by DXA and HR pQCT could discriminate fracture status in 211 adult men and women with stages 3 to 5 CKD, attending predialysis clinics in Toronto Canada, using logistic regression. Results are expressed as the odds ratio (OR) of fracture (prevalent vertebral and/or low trauma since age 40 years) per standard deviation decrease in the predictor adjusted for age, weight, sex, and CKD stage. We constructed receiver operating characteristic curves to examine the discriminative ability of BMD measures for fracture.
RESULTS: Most participants were Caucasian men with a mean age of 63.3 ± 15.5 years. There were 77 fractures in 74 participants. Decreases in BMD were associated with increased fracture risk: OR = 1.56 (95% confidence interval (CI), 1.41 to 1.71) for BMD by DXA at the ultradistal radius, and OR = 1.24 (95% CI, 1.12 to 1.36) for cortical area by HR pQCT. Further, while both tests were able to discriminate fracture status, the addition of HR pQCT measures to BMD by DXA did not improve fracture discrimination ability.
CONCLUSIONS: Among CKD patients not yet requiring renal replacement therapy, BMD by DXA is able to discriminate fracture status.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297732     DOI: 10.1007/s00198-012-1908-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Comparing the areas under more than two independent ROC curves.

Authors:  D K McClish
Journal:  Med Decis Making       Date:  1987 Jul-Sep       Impact factor: 2.583

3.  Renal function and risk of hip and vertebral fractures in older women.

Authors:  Kristine E Ensrud; Li-Ying Lui; Brent C Taylor; Areef Ishani; Michael G Shlipak; Katie L Stone; Jane A Cauley; Sophie A Jamal; Diana M Antoniucci; Steven R Cummings
Journal:  Arch Intern Med       Date:  2007-01-22

4.  Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial.

Authors:  Sophie A Jamal; Douglas C Bauer; Kristine E Ensrud; Jane A Cauley; Marc Hochberg; Areef Ishani; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2007-04       Impact factor: 6.741

5.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

6.  Relationship between moderate to severe kidney disease and hip fracture in the United States.

Authors:  Thomas L Nickolas; Donald J McMahon; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2006-09-27       Impact factor: 10.121

7.  High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures.

Authors:  Laurence Vico; Mohamed Zouch; Adel Amirouche; Delphine Frère; Norbert Laroche; Bruno Koller; Andres Laib; Thierry Thomas; Christian Alexandre
Journal:  J Bone Miner Res       Date:  2008-11       Impact factor: 6.741

8.  Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis.

Authors:  C R Russo; G Taccetti; P Caneva; A Mannarino; P Maranghi; M Ricca
Journal:  Osteoporos Int       Date:  1998       Impact factor: 4.507

9.  The effect of raloxifene treatment in postmenopausal women with CKD.

Authors:  Areef Ishani; Terri Blackwell; Sophie A Jamal; Steven R Cummings; Kristine E Ensrud
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

10.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.

Authors:  H K Genant; M Jergas; L Palermo; M Nevitt; R S Valentin; D Black; S R Cummings
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

View more
  34 in total

1.  Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.

Authors:  A-J Chang; Q Ying; X-N Chen; W-M Wang; N Chen
Journal:  Osteoporos Int       Date:  2016-07-08       Impact factor: 4.507

2.  High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.

Authors:  Hartmut H Malluche; Gustav Blomquist; Marie-Claude Monier-Faugere; Thomas L Cantor; Daniel L Davenport
Journal:  J Am Soc Nephrol       Date:  2015-04-02       Impact factor: 10.121

Review 3.  Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.

Authors:  Erin M B McNerny; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

4.  Alterations of bone microstructure and strength in end-stage renal failure.

Authors:  A Trombetti; C Stoermann; T Chevalley; B Van Rietbergen; F R Herrmann; P-Y Martin; R Rizzoli
Journal:  Osteoporos Int       Date:  2012-10-26       Impact factor: 4.507

5.  The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease.

Authors:  S A Jamal; S L West; T L Nickolas
Journal:  Osteoporos Int       Date:  2013-10-11       Impact factor: 4.507

6.  The utility of circulating markers to predict bone loss across the CKD spectrum.

Authors:  Thomas L Nickolas
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-19       Impact factor: 8.237

Review 7.  Bone imaging and fracture risk assessment in kidney disease.

Authors:  Sophie A Jamal; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

8.  Association of High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) bone microarchitectural parameters with previous clinical fracture in older men: The Osteoporotic Fractures in Men (MrOS) study.

Authors:  Howard A Fink; Lisa Langsetmo; Tien N Vo; Eric S Orwoll; John T Schousboe; Kristine E Ensrud
Journal:  Bone       Date:  2018-05-08       Impact factor: 4.398

9.  Rapid cortical bone loss in patients with chronic kidney disease.

Authors:  Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Kyle K Nishiyama; Mafo Komandah-Kosseh; Chiyuan A Zhang; Donald J McMahon; Xiaowei S Liu; Stephanie Boutroy; Serge Cremers; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2013-08       Impact factor: 6.741

Review 10.  Chronic kidney disease and osteoporosis: evaluation and management.

Authors:  Paul D Miller
Journal:  Bonekey Rep       Date:  2014-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.